CREB1 and depressive disorder: For instance, GSK-3β inhibitors may be used in conjunction with CREB activators (like rolipram) and BDNF enhancers (like 7,8-DHF) to promote neuroprotection, slow cognitive decline, and lessen depressive symptoms in AD and depression.